Back
TechTarget 10K Form
Sell
48
TTGT
TechTarget
Last Price:
29.31
Seasonality Move:
10.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | TTGT/TechTarget Quarterly |
| 2023-11-08 | 10Q | TTGT/TechTarget Quarterly |
| 2023-08-08 | 10Q | TTGT/TechTarget Quarterly |
| 2023-05-09 | 10Q | TTGT/TechTarget Quarterly |
| 2022-11-09 | 10Q | TTGT/TechTarget Quarterly |
| 2022-08-04 | 10Q | TTGT/TechTarget Quarterly |
Receive TTGT News And Ratings
See the #1 stock for the next 7 days that we like better than TTGT
TTGT Financial Statistics
Sales & Book Value
| Annual Sales: | $96.02B |
|---|---|
| Cash Flow: | $7.67M |
| Price / Cash Flow: | 18.04 |
| Annual Sales: | $8.29 |
| Price / Book: | 3.81 |
Profitability
| EPS (TTM): | -0.30000 |
|---|---|
| Net Income (TTM): | $-8.64M |
| Gross Margin: | $9.3B |
| Return on Equity: | -3.95% |
| Return on Assets: | -1.22% |
TechTarget Earnings Forecast
Key TechTarget Financial Ratios
- The Gross Profit Margin over the past 23 years for TTGT is 9.68%.
- The Selling, General & Administrative Expenses for TTGT have been equal to 6.87% of Gross Profit Margin.
- The Research & Development expenses have been 4.74% of Revenue.
- The Interest Expense is 16.48% of Operating Income.
- The Net Earning history of TTGT is 2.08% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 14 years.
TechTarget Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Media |
| Sector: | Communication Services |
| Current Symbol: | TTGT |
| CUSIP: | 87874R |
| Website: | techtarget.com |
Debt
| Debt-to-Equity Ratio: | 1.74 |
|---|---|
| Current Ratio: | 9.35 |
| Quick Ratio: | 9.19 |
Price-to-Earnings
| Trailing P/E Ratio: | 47.79 |
|---|---|
| Forward P/E Ratio: | 19.53 |
TTGT Technical Analysis vs Fundamental Analysis
Sell
48
TechTarget (TTGT)
is a Sell
Is TechTarget a Buy or a Sell?
-
TechTarget stock is rated a Sell
The current TechTarget [TTGT] share price is $32.34. The Score for TTGT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.